Level Biotechnology Inc. (3118)

Level Biotechnology Inc. (3118) is a leading biotech company established in 1989 in Taiwan with a primary focus on marketing and distributing a wide range of biotechnology products and precision equipment. In the year 2000, the company expanded its operations to include a Contract Research Organization (CRO) specializing in preclinical services for New Chemical Entities (NCE), Biopharmaceutics, Medical Devices, and related products. With a commitment to serving the biomedical community, Level Biotechnology Inc. has earned a stellar reputation worldwide for its customer-centric approach, knowledgeable sales team, efficient logistics operations, experienced management, and robust financial strategies. The company is ISO9001:2000 certified, reflecting its commitment to consistent service quality. The state-of-the-art CRO facilities of Level Biotechnology Inc. cover over 9,900 square yards of laboratory space. The animal facility has been accredited by AAALAC International since 2007, attesting to the company's dedication to maintaining high standards. The company has achieved accreditation for more than thirty testing items from the Taiwan Accreditation Foundation (TAF), aligning with the ISO 17025 guidelines. These credentials underscore the commitment of Level Biotechnology Inc. to delivering excellence in all aspects of its services. Currently, there is no available information on the last investment or the investors involved. Nevertheless, with its extensive experience, strong reputation, and foundation in the biotechnology and manufacturing industries, Level Biotechnology Inc. stands as a prominent player in the biomedical community.